BioCentury
ARTICLE | Clinical News

Revatio sildenafil regulatory update

January 11, 2010 8:00 AM UTC

The EC approved Pfizer's Revatio sildenafil injection to treat pulmonary arterial hypertension (PAH) in patients who are temporarily unable to take oral medicine but are otherwise clinically and hemod...